7 December 2020 

Moderna announced that it has expanded its supply agreement with the Ministry of Health of Israel by an additional four million doses of the mRNA-1273 vaccine for Covid-19. While the Ministry of Health in Israel is yet to complete regulatory approval for the vaccine, the country has secured access to six million doses of mRNA-1273 through the expanded agreement.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Clover Biopharmaceuticals announced positive clinical results from its Phase I trial . The results demonstrated that Clover’s protein-based Covid-19 S-Trimer vaccine candidates with GlaxoSmithKline or Dynavax adjuvants induced strong immune responses, including neutralising antibodies and cell-mediated immunity. The vaccines were also found to be safe and tolerable among 150 adults and elderly volunteers.

Eli Lilly and UnitedHealth Group are collaborating to study bamlanivimab (LY-CoV555) in high-risk, Covid-19 individuals in areas such as symptom tracking, in-home testing and in-home infusions to detect the SAR-CoV-2 virus. Bamlanivimab was recently granted emergency use authorisation by the US Food and Drug Administration (FDA) for treating mild to moderate Covid-19 patients who were at high risk of developing severe Covid-19 and/or hospitalisation.

The Drugs Controller General of India (DCGI) granted emergency use authorisation to Pfizer India for its Covid-19 vaccine, making it the first company to get the approval in the country and after its parent company secured clearance in the UK and Bahrain. Officials reported that the company has sought permission from the drug regulator to import the vaccine for sale and distribution in the country.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.